Skip to main content

Phoundry Pharmaceuticals Start-Up and Glucagon Project

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 18, 2015
Award amount: 
$50,000
Organization name: 
Phoundry Pharmaceuticals Inc
Principal Investigator: 
Feldman, Paul L
Grant program category: 
Business Financing
Grant program name: 
Company Inception Loan
Region: 
Research Triangle

Phoundry Pharmaceuticals Inc. is an RTP-based peptide therapeutic company focused on the treatment of diabetes. The company received $50,000 in funding to support start-up operations. Phoundry is a spin out of GSK.

Fiscal year: 
2015